Cargando…
Cancer vaccine strategies using self-replicating RNA viral platforms
The development and success of RNA-based vaccines targeting SARS-CoV-2 has awakened new interest in utilizing RNA vaccines against cancer, particularly in the emerging use of self-replicating RNA (srRNA) viral vaccine platforms. These vaccines are based on different single-stranded RNA viruses, whic...
Autores principales: | Dailey, Gabrielle P., Crosby, Erika J., Hartman, Zachary C. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group US
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9275542/ https://www.ncbi.nlm.nih.gov/pubmed/35821284 http://dx.doi.org/10.1038/s41417-022-00499-6 |
Ejemplares similares
-
Clinical trials of self-replicating RNA-based cancer vaccines
por: Morse, Michael A., et al.
Publicado: (2023) -
Beyond Neoantigens: Antigens Derived from Tumor Drivers as Cancer Vaccine Targets
por: Crosby, Erika J., et al.
Publicado: (2023) -
Cancer vaccines: the importance of targeting oncogenic drivers and the utility of combinations with immune checkpoint inhibitors
por: Crosby, Erika J., et al.
Publicado: (2021) -
Double-Membrane Vesicles as Platforms for Viral Replication
por: Wolff, Georg, et al.
Publicado: (2020) -
Replicating and non-replicating viral vectors for vaccine development
por: Robert-Guroff, Marjorie
Publicado: (2007)